These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16434340)

  • 1. Fosphenytoin may cause hemodynamically unstable bradydysrhythmias.
    Adams BD; Buckley NH; Kim JY; Tipps LB
    J Emerg Med; 2006 Jan; 30(1):75-9. PubMed ID: 16434340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Literature Review Revisiting Phenytoin-Induced Sinus Arrest.
    Parsai S; Hariri I; Taleb M; Yoon Y
    Am J Ther; 2016; 23(4):e1091-3. PubMed ID: 25549077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety, tolerability, and pharmacokinetics of fosphenytoin after intramuscular and intravenous administration in neurosurgery patients.
    Boucher BA; Feler CA; Dean JC; Michie DD; Tipton BK; Smith KR; Kramer RE; Young B; Parks BR; Kugler AR
    Pharmacotherapy; 1996; 16(4):638-45. PubMed ID: 8840370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac arrest after fast intravenous infusion of phenytoin mistaken for fosphenytoin.
    DeToledo JC; Lowe MR; Rabinstein A; Villaviza N
    Epilepsia; 2001 Feb; 42(2):288. PubMed ID: 11240605
    [No Abstract]   [Full Text] [Related]  

  • 5. [Management of convulsive status epilepticus in infants and children].
    Hubert P; Parain D; Vallée L
    Rev Neurol (Paris); 2009 Apr; 165(4):390-7. PubMed ID: 19264335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric drug surveillance and the Food and Drug Administration's adverse event reporting system: an overview of reports, 2003-2007.
    Johann-Liang R; Wyeth J; Chen M; Cope JU
    Pharmacoepidemiol Drug Saf; 2009 Jan; 18(1):24-7. PubMed ID: 19009550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and risk factors of hypotension after intravenous fosphenytoin administration.
    Kim HK; Hwang IG; Koh IS; Kim DW
    J Clin Pharm Ther; 2017 Oct; 42(5):561-566. PubMed ID: 28439951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and clinical effects of phenytoin and fosphenytoin in children with severe malaria and status epilepticus.
    Ogutu BR; Newton CR; Muchohi SN; Otieno GO; Edwards G; Watkins WM; Kokwaro GO
    Br J Clin Pharmacol; 2003 Jul; 56(1):112-9. PubMed ID: 12848783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is phenytoin administration safe in a hypothermic child?
    Bhagat H; Bithal PK; Chouhan RS; Arora R
    J Clin Neurosci; 2006 Nov; 13(9):953-5. PubMed ID: 17049862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appropriateness of intravenous loading dose of phenytoin treatment in Srinagarind Hospital.
    Tiamkao S; Chitravas N; Jitpimolmard S; Sawanyawisuth K
    J Med Assoc Thai; 2005 Nov; 88(11):1638-41. PubMed ID: 16471113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety and efficacy of fosphenytoin for the treatment of status epilepticus.
    Popławska M; Borowicz KK; Czuczwar SJ
    Expert Rev Neurother; 2015; 15(9):983-92. PubMed ID: 26289487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inappropriate fosphenytoin use in the ED.
    Johnson J; Wrenn K
    Am J Emerg Med; 2001 Jul; 19(4):293-4. PubMed ID: 11447516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fosphenytoin.
    Eriksson K; Keränen T; Kälviäinen R
    Expert Opin Drug Metab Toxicol; 2009 Jun; 5(6):695-701. PubMed ID: 19473113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fosphenytoin and phenytoin in patients with status epilepticus: improved tolerability versus increased costs.
    DeToledo JC; Ramsay RE
    Drug Saf; 2000 Jun; 22(6):459-66. PubMed ID: 10877039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience with fosphenytoin in adults: pharmacokinetics, safety, and efficacy.
    Knapp LE; Kugler AR
    J Child Neurol; 1998 Oct; 13 Suppl 1():S15-8; discussion S30-2. PubMed ID: 9796747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advisers recommend improved labeling for phenytoin, fosphenytoin.
    Traynor K
    Am J Health Syst Pharm; 2010 Dec; 67(24):2086, 2089. PubMed ID: 21115998
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypocalcemia-like electrocardiographic changes after administration of intravenous fosphenytoin.
    Keegan MT; Bondy LR; Blackshear JL; Lanier WL
    Mayo Clin Proc; 2002 Jun; 77(6):584-6. PubMed ID: 12059129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purple Glove Syndrome after Phenytoin or Fosphenytoin Administration: Review of Reported Cases and Recommendations for Prevention.
    Garbovsky LA; Drumheller BC; Perrone J
    J Med Toxicol; 2015 Dec; 11(4):445-59. PubMed ID: 26135797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serious adverse drug events reported to the Food and Drug Administration, 1998-2005.
    Moore TJ; Cohen MR; Furberg CD
    Arch Intern Med; 2007 Sep; 167(16):1752-9. PubMed ID: 17846394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Requirement for cardiac telemetry during intravenous phenytoin infusion: guideline fact or guideline fiction?
    Siebert WJ; McGavigan AD
    Intern Med J; 2013 Jan; 43(1):7-17. PubMed ID: 22947413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.